How to Simplify the Evaluation of Newly Introduced Chemotherapeutic Interventions in Myeloma

When the bortezomib [PS341], adriamycin and dexamethasone (PAD) regimen was first evaluated, the response rate in untreated patients was much superior to that elicited by conventional chemotherapeutic agents. We demonstrated the efficacy of PAD in relapsed or refractory patients by comparing the res...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Treen Carson Michael, Drake, Mary B., Kettle, Paul J., McGuigan, Tracey, Leahy, Maeve, O’Dwyer, Michael, Enright, Helen, O’Shea, Tanya, Popat, Rakesh, Oakervee, Heather E., Yong, Kwee, Cavenagh, Jamie D., Cairns, David A., Alvarez-Iglesias, Alberto, Cook, Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432324/
https://www.ncbi.nlm.nih.gov/pubmed/34595464
http://dx.doi.org/10.2991/chi.k.210201.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432324/
https://www.ncbi.nlm.nih.gov/pubmed/34595464
http://dx.doi.org/10.2991/chi.k.210201.001

Ejemplares similares